After Yusimry's Discount, Future Adalimumab Pricing Unclear at HealthBulance.

Health care is our expertise. Adalimumab, sold under the brand name Humira, enjoyed a long run as one of the world's best-selling medicines. But its 20-year, competition-free period has ended, and despite its best efforts to delay their arrival, drug manufacturer AbbVie now faces increasing

Medscape

After Yusimry's Discount, Future Adalimumab Pricing Unclear

After Yusimry's Discount, Future Adalimumab Pricing Unclear

Adalimumab, sold under the brand name Humira, enjoyed a long run as one of the world's best-selling medicines. But its 20-year, competition-free period has ended, and despite its best efforts to delay their arrival, drug manufacturer AbbVie now faces increasing competition from biosimilars entering the marketplace.